Clinical efficacy of gamma-oryzanol combined with Femoston for perimenopausal syndrome

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

677

Figures (1-3)

158

Tables (1-3)

157

Sum=1030

Publishing Process of This Article

Item

Count

Browse

Download

156

Sum=194

Aug 6, 2024 (publication date) through Jan 26, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Aug 6, 2024; 12(22): 4992-4998
Published online Aug 6, 2024. doi: 10.12998/wjcc.v12.i22.4992

Table 2 Comparative analysis of clinical effectiveness, n (%)

Citation: Kuang YY, Xiong MQ, Cai JX. Clinical efficacy of gamma-oryzanol combined with Femoston for perimenopausal syndrome. World J Clin Cases 2024; 12(22): 4992-4998
URL: https://www.wjgnet.com/2307-8960/full/v12/i22/4992.htm
DOI: https://dx.doi.org/10.12998/wjcc.v12.i22.4992